Structural basis of second-generation HIV integrase inhibitor action and viral resistance
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Strengths and weaknesses of an HIV drug: Retroviruses replicate by inserting a copy of their RNA, which has been reverse transcribed into DNA, into the host genome. This process involves the intasome, a nucleoprotein complex comprising copies of the viral integrase bound at the ends of the viral DNA. HIV integrase strand-transfer inhibitors (INSTIs) stop HIV from replicating by blocking the viral integrase and are widely used in HIV treatment. Cook et al. describe structures of second-generation inhibitors bound to the simian immunodeficiency virus (SIV) intasome and to an intasome with integrase mutations known to cause drug resistance. Passos et al. describe the structures of the HIV intasome bound to a second-generation inhibitor and to developmental compounds that are promising drug leads. These structures show how mutations can cause subtle changes in the active site that affect drug binding, show the basis for the higher activity of later-generation inhibitors, and may guide development of better drugs. Science , this issue p. 806 , p. 810
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with their function, all intasomes feature 2-fold symmetry and harbour a pair of juxtaposed active sites engaged with 3’ vDNA ends.”
From Structure and function of retroviral integrase (2022) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite these differences, all intasomes incorporate the conserved intasome core (CIC) assembly, which is the minimal functional unit and is represented by the PFV structure (Figs. 2A, 3).”
From Structure and function of retroviral integrase (2022) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The structures revealed unexpected architectural diversity among intasomes from different retroviral genera.”
From Structure and function of retroviral integrase (2022) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The stoichiometric state of primate lentiviral intasomes from HIV-1 and the simian immunodeficiency virus (SIV) remain a subject of debate, with complexes containing four and eight to sixteen IN molecules observed by cryo-EM and negative stain electron microscopy33–36.”
From Structure and function of retroviral integrase (2022) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, LEDGF/p75 was instrumental to reconstitute lentiviral intasomes for structural characterisation32–36.”
From Structure and function of retroviral integrase (2022) · cites this paper as [35]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Density-functional thermochemistry. III. The role of exact exchange
Becke, A. D. (1993) · The Journal of Chemical Physics · doi:10.1063/1.464913 · Cited by 103,767
Weigend, F., & Ahlrichs, R. (2005) · Physical Chemistry Chemical Physics · doi:10.1039/b508541a · Cited by 30,598
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
Development and testing of a general amber force field
Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A., & Case, D. A. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20035 · Cited by 19,506
Intermolecular interactions from a natural bond orbital, donor-acceptor viewpoint
Reed, A. E., Curtiss, L. A., & Weinhold, F. (1988) · Chemical Reviews · doi:10.1021/cr00088a005 · Cited by 17,359
Scalable molecular dynamics with NAMD
Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., Chipot, C., Skeel, R. D., Kalé, L., & Schulten, K. (2005) · Journal of Computational Chemistry · doi:10.1002/jcc.20289 · Cited by 16,914
Hehre, W. J., Ditchfield, R., & Pople, J. A. (1972) · The Journal of Chemical Physics · doi:10.1063/1.1677527 · Cited by 15,855
Long-range corrected hybrid density functionals with damped atom–atom dispersion corrections
Chai, J.-D., & Head-Gordon, M. (2008) · Physical Chemistry Chemical Physics · doi:10.1039/b810189b · Cited by 14,648
cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
Punjani, A., Rubinstein, J. L., Fleet, D. J., & Brubaker, M. A. (2017) · Nature Methods · doi:10.1038/nmeth.4169 · Cited by 11,626
Ditchfield, R., Hehre, W. J., & Pople, J. A. (1971) · The Journal of Chemical Physics · doi:10.1063/1.1674902 · Cited by 10,612
Cited by
Items 101–112 of 112
Molecular basis of the interaction between HIV-1 integrase and viral RNA
Rocchi, C. (2022) · theses.fr (ABES) · doi:10.70675/56a488fez1f79z4d34z81d9z905314a2ca30
Temporal Evolution of Drug Resistance to HIV Integrase Inhibitors
Choudhuri, I., Olvera, J. G., Biswas, A., Haldane, A., Levy, R. M., & Lyumkis, D. (2026) · Viruses · doi:10.3390/v18050540 · Cited by 2
“INSTIs engage the active site of IN in the context of the intasome, forming bonds with both the enzyme and vDNA ends [6,9–11].”
Non-integrase mechanisms for dolutegravir resistance
Engelman, A. (2026) · Retrovirology · doi:10.1186/s12977-026-00678-5 · Cited by 1
“Visualization of INSTI-bound CSC intasomes constructed from drug-resistant IN mutant proteins has revealed that resistance changes generally effect the polarization of the Mg 2+ ions, weakening the chelation of the bound drug [67, 87].”
Self-citationHou, X., Huang, M., Zhang, Q., Yao, Q., & Yang, J. (2026) · RSC Advances · doi:10.1039/d6ra04127b
Saccoliti, F., Patacchini, E., Cara, E., Zarbo, L., Messore, A., Albano, A., Ruggieri, G., Madia, V. N., Scipione, L., Costi, R., et al. (2026) · ChemMedChem · doi:10.1002/cmdc.70428 · Cited by 1
“All IN inhibitors currently approved for clinical use belong to the class of INSTIs, which selectively block the ST reaction by chelating the two Mg 2 + ions within the CCD, thereby preventing the stable integration of the viral dsDNA into the host genome [4 – 6, 12, 32, 44, 45].”
Alqaaf, M., Mamun, M. A. A., Nasution, A. K., Islam, A. S. M. N., Supriyanti, R., Ono, N., Kanaya, S., & Altaf-Ul-Amin, M. (2026) · Pharmaceuticals · doi:10.3390/ph19101534
“For integrase, the combination of hydrogen bonding and aromatic stacking predicted for C00002145 resembles the binding mode of raltegravir and related integrase strand-transfer inhibitors (INSTIs), which use aromatic interactions with active-site residues and viral DNA for stabilization [8,9,45,52].”
InfluentialBindingDB Entry 50022399: Fluorine in anti-HIV drugs approved by FDA from 1981 to 2023.
BindingDB (2025) · UC San Diego · doi:10.7270/q23201k8
Singh, P. (2026) · Harvard Dataverse · doi:10.7910/dvn/udt6uc
BindingDB Entry 50018529: Advances in the development of HIV integrase strand transfer inhibitors.
BindingDB (2024) · UC San Diego · doi:10.7270/q25143gj
Processed HIV-1 integration site datasets from Jurkat cells with capsid mutants
Singh, P. (2026) · Harvard Dataverse · doi:10.7910/dvn/xrkmnr
BindingDB Entry 50018412: Targeting Metalloenzymes by Boron-Containing Metal-Binding Pharmacophores.
BindingDB (2024) · UC San Diego · doi:10.7270/q2w09b41
Metadata
- Authors
- Cook, N. J., Li, W., Berta, D., Badaoui, M., Ballandras-Colas, A., Nans, A., Kotecha, A., Rosta, E., Engelman, A. N., & Cherepanov, P.
- Affiliations
- The Francis Crick Institute (GB)
- Harvard University (US)
- King's College London (GB)
- Centre for Human Genetics (GB)
- Corresponding author
- Engelman, Alan N.
- Cherepanov, Peter
- ORCID
- Venue
- Science
- Published
- 2020-02-14
- Volume
- 367
- Issue
- 6479
- Pages
- 806-810
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC7023979
- OpenAlex
- W3004171189
- Cited by
- 108
- References
- 64
- Citations by year
- 2026: 12 · 2025: 11 · 2024: 18 · 2023: 18 · 2022: 16 · 2021: 20 · 2020: 13
- FWCI
- 2.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- National Institutes of Health (AI150481, AI070042)
- Francis Crick Institute (FC001061)
- Medical Research Council (FC001061)
- Engineering and Physical Sciences Research Council (EP/R013012/1)
- European Research Council (757850 BioNet)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Keywords
- HIV integrase, integrase strand transfer inhibitors, dolutegravir, bictegravir, integrase inhibitors, drug resistance, magnesium coordination, protein-ligand binding, antiretroviral drug design
- MeSH terms
- Single Molecule Imaging, Dolutegravir, Amides, Glutamine, Glycine, Heterocyclic Compounds, 3-Ring, Heterocyclic Compounds, 4 or More Rings, Histidine, Humans, Magnesium, Mutation, Oxazines, Piperazines, Pyridones, Serine, HIV Integrase, HIV Integrase Inhibitors, Amino Acid Substitution, Catalytic Domain, Cryoelectron Microscopy, Drug Resistance, Viral
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.